# Vyondys 53

NDC: 60923-465
Generic name: golodirsen
Labeler / Manufacturer: Sarepta Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20191212

FDA application: NDA211970

## Active ingredients

- GOLODIRSEN: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60923-465"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60923-465
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5